In a report released today, Rahul Anand from Morgan Stanley maintained a Sell rating on IGO, with a price target of A$4.50. According to TipRanks, Anand is a 5-star analyst with an average return of ...
POTOMAC, MARYLAND / ACCESS Newswire / November 13, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging Artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback